ScholarIQanswers from OpenAlex

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

PaperCitations, authors & open-access status

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress have?

ScholarIQcitation count

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress has 178 citations in the OpenAlex counts ScholarIQ stores.

When was Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress published?

ScholarIQyear

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress has 2021 year in the ScholarIQ index.

What is the open-access status of Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress?

ScholarIQoa status

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress has bronze oa status in the ScholarIQ index.

What is the DOI of Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress?

ScholarIQdoi

The DOI for Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress is on the source record.

What is the PMID of Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress?

ScholarIQpmid

The PMID for Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress is on the source record.

What is the OpenAlex record for Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress?

ScholarIQopenalex

The OpenAlex for Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial